David Topper

Chief Financial Officer

Mr Topper joined Arcutis in April 2024 as chief financial officer and is responsible for overseeing and managing all financial operations for Arcutis.  Mr Topper brings more than 40 years of professional experience in banking, investment management, and corporate operations,  with a proven record of leading and advising on capital markets activities including initial public offerings, follow-on offerings, mergers and acquisitions, debt financings, and derivatives. Prior to Arcutis, Mr Topper was CFO of Inmagene Biopharmaceuticals, a global clinical stage pharmaceutical company. Prior to Inmagene, Mr Topper held significant positions in various organizations, including serving as a partner for capital markets at General Atlantic and Frazier Healthcare Life Sciences. He also acted as CFO and board director at Frazier Life Sciences Acquisition Corp. Previously, he worked for six years at J.P. Morgan as co-head of Equity Capital Markets, Vice Chairman, and Chairman of the Commitments Committee.  Prior to JPM, Mr Topper was at Morgan Stanley for 22 years, where he held a number of leadership positions including co-head of Equity Capital Markets and managing director. Mr Topper holds an MBA from Stanford University and a BA from Duke University.